Brigham and Women's Hospital
Neurology
I am working as a Postdoctoral Researcher at the Brigham and Women’s Hospital & Harvard Medical School in Boston, USA. Before, I completed my PhD at the AUMC Amsterdam. My current research topics are (1) studying the cellular correlates of and mechanisms underlying PD sex differences in a ‘3K’ mouse model of alpha-synucleinopathy (2) exploring the impact of increasing palmitoylation of proteins - in particular estrogen-receptor alpha- on alpha-synuclein-induced synaptic pathology in 3K mice (3) unraveling the detailed architecture of (early) alpha-synuclein cytopathology in the post-mortem brain of donors with PD and in experimental PD model systems by super-resolution microscopy techniques and EM. Some of my other research interests are cellular processes involved in degradation of alpha-synuclein (lysosomal system/UPS) and alpha-synuclein interactions with lipid membranes. I am excited and very much looking forward to discussing my work during AD/PD2022 in Barcelona, please feel free to reach out to me in case of questions!

Presenter of 1 Presentation

SYNAPTIC ESTROGEN RECEPTOR ALPHA IMPROVES E46K-AMPLIFIED 3K ALPHA-SYNUCLEIN NEUROPATHOLOGY AND PHENOTYPES IN MICE

Session Type
SYMPOSIUM
Date
Thu, 17.03.2022
Session Time
09:10 AM - 10:40 AM
Room
ONSITE: 133-134
Lecture Time
09:55 AM - 10:10 AM

Abstract

Aims

Women are less vulnerable to neurodegenerative aspects of PD. We previously reported preserved alpha-synuclein (aSyn) homeostasis and reduced dopaminergic loss in female E46K-amplified (3K) aSyn transgenic mice, while estrogen treatment alleviated aSyn pathology and motor phenotypes in male 3K mice. Here, we study the underlying protective effects of estrogen receptor alpha (ERa) and impact of inhibiting the enzyme removing its membrane-stabilizing palmitoyl-tag in physiologically low 3K aSyn-expressing (3KL) mice.

Methods

Cognitive and motor performances were tested in various behavioral paradigms. We applied immunohistochemistry, (super-resolution) microscopy and immuno-EM to assess (sub)cellular localization and histopathology of aSyn and other proteins, quantitative WB/ELISA to study protein levels and biochemical distribution, and electrophysiology on hippocampal tissue slices to analyze synaptic plasticity. Estrogen receptor palmitoylation was measured using Acyl-Biotin Exchange assays.

Results

3KL female mice showed delayed onset of cognitive and motor symptoms, improved aSyn homeostasis (e.g. increased solubility/multimerization) and reduced Ser129-p aSyn cytopathology. Crowding of aSyn at vesicles was associated with impaired synaptic plasticity in 3KL males. Synaptic function was restored after estrogen treatment, which was blocked by ERa antagonists. In 3KL mice, ERa co-clustered at perinuclear and synaptic aSyn accumulations (as in the PD brain), which was associated with decreased ERa palmitoylation. We hence pharmacologically increased ERa palmitoylation using ML-348 (an APT-1 inhibitor) for 80 days, which improved synaptic plasticity and cognitive performances in 3KL (female and male) mice.

Conclusions

Increased synaptic ERa by female sex or ML-348-dependent palmitoylation preserves synaptic plasticity and aids phenotypes downstream the disturbed aSyn homeostasis in a 3KL aSyn PD mouse model.

Hide